Global Wound Debridement Market Report 2018 by Product, Method, Wound Type, and End-User - Forecast to 2023
DUBLIN, June 27, 2018 /PRNewswire/ --
The "Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global wound debridement market is expected to reach USD 1,041 Million by 2023 from USD 702 Million in 2018, at a CAGR of 8.2%. Factors such as rising incidence of diabetes & associated wounds, growing aging population, rising incidence of burn injuries, and growing awareness programs for wound care treatment and management are driving the growth of the wound debridement market.
The global wound debridement market is segmented by product, wound type, method, end user, and region. Based on products, the wound debridement market is segmented into gels, ointments & creams, surgical devices, ultrasound devices, mechanical debridement pads, medical gauzes, and other wound debridement products. Of all these product segments, gels accounted for the largest share of the market in 2017. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of gels. Gels are safe and effective, do not cause inflammation, and remove necrotic tissue from wounds.
Based on wound type, the wound debridement market has been segmented into venous leg ulcers (VLUs), diabetic foot ulcers (DFUs), pressure ulcers, surgical & traumatic wounds, burns, and other wounds. The VLUs segment is expected to offer growth opportunities for market players during the forecast period, primarily due to the growing patient pool for the condition. Apart from this, the DFUs segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the increasing prevalence of diabetes globally.
Based on end user, the wound debridement market has been segmented into hospitals, clinics, and other end users. In 2018, the hospitals segment is estimated to account for the largest market share. The availability of infrastructure and the presence of skilled professionals in hospitals are the major driving factors for this segment.
The global wound debridement market is dominated by North America, followed by Europe. North America will continue to dominate the global wound debridement market in the forecast period. However, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. Growth in this market is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.
Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mlnlycke Health Care AB (Sweden), and Integra LifeSciences (US) have been identified as key players in this market. These companies have broad product portfolios with comprehensive features. These leaders also have products for all end users in this market, a strong geographical presence, and a focus on continuous product innovation.
Companies Mentioned
- B. Braun Melsungen AG
- Coloplast
- Convatec Group
- Deroyal Industries
- Integra Lifesciences
- Lohmann & Rauscher
- Medline Industries
- Misonix
- Mlnlycke Health Care AB
- Smith & Nephew
- Welcare Industries
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Wound Debridement Market Overview
4.2 Asia Pacific: Wound Debridement Market, By Product & Country
4.3 Wound Debridement Market, By Region
4.4 Geographical Snapshot of the Wound Debridement Market (By Major Countries)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Diabetes and Associated Wounds
5.2.1.2 Growth in the Aging Population
5.2.1.3 Rising Incidence of Burn Injuries
5.2.1.4 Awareness Programs for Wound Care Treatment and Management
5.2.2 Market Opportunities
5.2.2.1 Lucrative Opportunities for New Entrants
5.2.2.2 Growth Potential of Emerging Economies
5.2.3 Market Trend
5.2.3.1 Focus on Autolytic Debridement & Disposable Products
6 Wound Debridement Market, By Product
6.1 Introduction
6.2 Gels
6.3 Ointments & Creams
6.4 Surgical Devices
6.5 Medical Gauzes
6.6 Mechanical Debridement Pads
6.7 Ultrasonic Devices
6.8 Other Wound Debridement Products
7 Wound Debridement Market, By Wound Type
7.1 Introduction
7.2 Venous Leg Ulcers
7.3 Diabetic Foot Ulcers
7.4 Pressure Ulcers
7.5 Surgical & Traumatic Wounds
7.6 Burns
7.7 Other Wounds
8 Wound Debridement Market, By Method
8.1 Introduction
8.2 Autolytic Methods
8.3 Enzymatic Methods
8.4 Surgical Methods
8.5 Mechanical Methods
8.6 Other Methods
9 Wound Debridement Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Other End Users
10 Wound Debridement Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 RoE
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Expansions
11.3.2 Product Launches
11.3.3 Collaborations
11.3.4 Acquisitions
12 Company Profiles
12.1 Smith & Nephew
12.2 B. Braun Melsungen AG
12.3 Coloplast
12.4 Misonix
12.5 Convatec Group
12.6 Lohmann & Rauscher
12.7 Deroyal Industries
12.8 Medline Industries
12.9 Mlnlycke Health Care AB
12.10 Integra Lifesciences
12.11 Welcare Industries
For more information about this report visit https://www.researchandmarkets.com/research/88bp8z/global_wound?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article